Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741687 | PMC |
http://dx.doi.org/10.1001/archopht.126.8.1152 | DOI Listing |
Retin Cases Brief Rep
November 2014
From the *Department of Ophthalmology, Changhua Christian Hospital, Changhua County, Taiwan; †Department of Optometry, Chung Hwa University of Medical Technology, Tainan County, Taiwan; and ‡School of Medicine, Chung Shan Medical University, Taichung City, Taiwan; and §Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan.
Purpose: To report the effects of oral trimethoprim/sulfamethoxazole and intravitreal bevacizumab injection in the treatment of ocular toxoplasmosis-associated choroidal neovascular lesions (CNV).
Methods: This was a noncomparative, nonrandomized, consecutive case series. All eyes with ocular toxoplasmosis-associated CNV received one intravitreal bevacizumab injection under the coverage of oral trimethoprim/sulfamethoxazole.
Arch Ophthalmol
August 2008
University of Chicago, AMBH S206, 5841 S Maryland Ave, Chicago, IL 60637, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!